Diabetic Foot Vascular Disease

Pathophysiology - Sweet Vessel Sabotage

Chronic hyperglycemia fuels vascular damage through multiple pathways:

• Macrovascular Disease: Accelerated atherosclerosis.
  • Affects larger arteries, especially infrapopliteal (tibial, peroneal).
  • Leads to stenosis and occlusion.
• Microvascular Disease:
  • Capillary basement membrane thickening, impaired perfusion.
  • Endothelial cell damage.
• Key Mechanisms:
  • Endothelial Dysfunction: ↓ Nitric Oxide ($NO$) synthesis/bioavailability, ↑ Endothelin-1.
  • AGEs (Advanced Glycation End Products): Accumulate, causing vascular stiffness, inflammation, prothrombotic state.
  • Oxidative Stress: ↑ Reactive Oxygen Species (ROS) damage endothelium.
  • Inflammation: Chronic low-grade inflammation.
• Neuropathy's Vascular Impact:
  • Autonomic neuropathy: impaired vasoregulation, AV shunting.
  • Sensory/Motor neuropathy (e.g., Charcot foot): abnormal pressures, ulceration, ↑ infection risk, ↑ vascular demand.

⭐ Diabetic patients often develop infrapopliteal arterial disease, affecting tibial and peroneal arteries more severely than non-diabetics.

Clinical Presentation & Diagnosis - Foot's SOS Signals

• Symptoms: Intermittent claudication, rest pain, non-healing ulcers, gangrene.
• Signs: Diminished/absent pulses; skin changes (shiny, atrophic, hair loss); dependent rubor, pallor on elevation. 📌 Chronic PAD "SOS": Skin changes, Ongoing pain, Slow/absent pulses.
• Key Diagnostics:
  • Ankle-Brachial Index (ABI): $ABI = \text{Highest Ankle Systolic Pressure} / \text{Highest Brachial Systolic Pressure}$.
    • PAD: ABI < 0.9. CLI: ABI < 0.4.
  • Toe-Brachial Index (TBI): TBI < 0.7 (esp. if ABI unreliable due to calcification).
  • Doppler & Duplex Ultrasound: Initial imaging.
  • CTA/MRA, DSA (gold standard): Detailed anatomy & intervention planning.

⭐ Monofilament testing primarily assesses neuropathy, but its findings often coexist with vascular disease, indicating high-risk foot.

Classification Systems - Grading the Grief

Classification systems are crucial for assessing diabetic foot disease severity and guiding management.

Management Strategies - Saving Soles & Stems

• Conservative & Medical Therapy:
  • Risk factor control: Glycemia (HbA1c < 7%), BP < 130/80 mmHg, statins, antiplatelets (Aspirin/Clopidogrel).
  • Lifestyle: Crucial smoking cessation, structured exercise.
  • Pharmacologic: Cilostazol for claudication symptoms.
• Revascularization Options:
  • Endovascular (EVT): PTA, stenting, atherectomy. Often first-line for suitable lesions.
  • Surgical Bypass: Autogenous vein (e.g., saphenous) preferred for extensive disease or failed EVT.
• Wound Care & Adjunctive Measures:
  • Local: Debridement, appropriate dressings, infection control.
  • Offloading: Essential (e.g., Total Contact Cast).
  • Hyperbaric Oxygen Therapy (HBOT): Adjunctive for select non-healing wounds.
• Amputation (Last Resort):
  • For non-salvageable limb, uncontrolled sepsis, or to save life.

⭐ For diabetic patients with CLI & extensive infrapopliteal disease, distal bypass with autogenous vein offers best long-term patency if EVT is unsuitable.

High‑Yield Points - ⚡ Biggest Takeaways

• Diabetic foot ulcers (DFU) primarily result from neuropathy and peripheral artery disease (PAD).
• Wagner and University of Texas (UT) systems are key for DFU classification.
• Ankle-Brachial Index (ABI) < 0.9 suggests PAD; ABI < 0.4 indicates critical limb ischemia.
• Management pillars: glycemic control, wound care, offloading, and revascularization if PAD is present.
• Charcot neuroarthropathy is a major, deforming complication requiring prompt recognition.
• Multidisciplinary team approach and patient education are crucial for limb salvage.